Company intelligence / Profile preview

111 Minutes

Ownership: Private
Development stage: Other

Overview

"111" or "111, Inc." operates one of China's leading integrated online and offline healthcare platforms. It provides access to pharmaceutical products and healthcare services through its online retail pharmacy and offline network. The company also offers telemedicine via its internet hospital ("1 Clinic"), electronic prescription services, and supports pharmacies with its wholesale marketplace ("1 Drug Mall"). Its smart supply chain modernizes pharmaceutical distribution across China.

Industry: Non-Academic Healthcare

Partnerships

Strategic partnership with BeiGene for innovative medicine commercialization in China.

Beyond the preview

Go deeper on 111 Minutes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 111 Minutes.

Explore the full profile